Double blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low dose oral prednisolone in Pityriasis Rosea<sup/>.
Author | |
---|---|
Abstract |
:
To evaluate the efficacy and safety of short-course low-dose oral prednisolone in symptomatic pityriasis rosea (PR) of onset less than 5 days and compare it with placebo. |
Year of Publication |
:
2018
|
Journal |
:
The Journal of dermatological treatment
|
Number of Pages |
:
1-23
|
Date Published |
:
2018
|
ISSN Number |
:
0954-6634
|
URL |
:
http://www.tandfonline.com/doi/full/10.1080/09546634.2018.1430302
|
DOI |
:
10.1080/09546634.2018.1430302
|
Short Title |
:
J Dermatolog Treat
|
Download citation |